Abstract
Summary: This article summarizes data and issues covered in the workshop on Glycine Encephalopathy using headings that cover important topics in our present knowledge of this disease.
Presenters were: Dr Ada Hamosh (Baltimore); Dr Johan L. K. Van Hove (Leuven); Dr Christine Vianey-Saban (Lyon); Dr Shigeo Kure (Sendai); Dr A. Ichinohe (Sendai); Jennifer Toone (Vancouver); Dr Stanley Korman (Jerusalem).
This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Aliefendioglu D, Aslan AT, Coskun T, Dursun A, Cakmak FN, Kesimer M (2003) Transient nonketotic hyperglycinemia: two case reports and literature review. Pediatr Neurol 28: 151–155.
Applegarth DA, Toone JR, Rolland MO, Black SH, Yim DKC, Bemis G (2000) Non-concordance of CVS and liver glycine cleavage enzyme in 3 families with NKH leading to false negative prenatal diagnosis. Prenat Diagn 20: 367–370.
Boneh A, Degani Y, Harani M (1996) Diagnostic clues and outcome of early treatment of NKH. Pediatr Neurol 15: 137–141.
Hamosh A, Van Hove JLK (2003) Concerns regarding transience and heterozygosity in neonatal hyperglycinemia. Ann Neurol 53: 685.
Hiraga K, Kochi H, Hayasaka K, Kikuchi G, Nyhan WL (1981) Defective glycine cleavage system in non-ketotic hyperglycinemia. J Clin Invest 68: 525–534.
Hoover-Fong JE, Shah S, Van Hove JLK, Applegarth DA, Toone JR, Hamosh A (2003) Natural history of glycine encephalopathy in 65 patients. J Inherit Metab Dis 26(2): 64.
Ichinohe A, Kojima K, Aoki Y, et al (2003) Seizures and brain malformations in model mice for glycine encephalopathy. J Inherit Metab Dis 26(2): 65.
Kojima K, Ichinohe A, Aoki Y, et al (2003) Activity, convulsiveness, aggressiveness, and anxiety in transgenic mice with altered glycine concentrations in central nervous system. J Inherit Metab Dis 26(2): 77.
Korman SH, Boneh A, Gutman A, et al (2003) A novel glycine encephalopathy (NKH) variant: absent or transient symptoms but persisting biochemical features. J Inherit Metab Dis 26(2): 66.
Kure S, Kojima K, Ichinohe A, et al (2002) Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia. Ann Neurol 52: 643–646.
Kure S, Kojima K, Ichinohe A, Aoki Y, Suzuki Y, Matsubara Y (2003) A comprehensive mutation analysis of GLDC, AMT, and GCSH in glycine encephalopathy. J Inherit Metab Dis 26(2): 66.
Tada K, Kure SJ (1993) Non-ketotic hyperglycinemia: molecular lesion, diagnosis and pathophysiology. J Inherit Metab Dis 16: 691–703.
Toone JR, Applegarth DA, Coulter-Mackie MB, James ER (2000) Biochemical and molecular investigations of patients with nonketotic hyperglycinemia (NKH). Mol Genet Metab 70: 116–121.
Toone JR, Applegarth DA, Choy F, Coulter-Mackie MB (2003) The Vancouver experience in the diagnosis of glycine encephalopathy (NKH). J Inherit Metab Dis 26(2): 70.
Van Hove JLK, Mahieu V, Schollen E, et al (2003) Prognosis in nonketotic hyperglycinemia. J Inherit Metab Dis 26(2): 71.
Vianey Saban C, Chevalier-Porst F, Froissart R, Rolland MO (2003) Prenatal diagnosis of nonketotic hyperglycinemia: a 13-year experience, from enzymatic to molecular analysis. J Inherit Metab Dis 26(2): 82.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Applegarth, D.A., Toone, J.R. Glycine encephalopathy (nonketotic hyperglycinaemia): Review and update. J Inherit Metab Dis 27, 417–422 (2004). https://doi.org/10.1023/B:BOLI.0000031222.38328.59
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000031222.38328.59